Importantly, knockdown of CDH1 overturned the prohibitive impacts of silencing miR-106a on proliferation, invasion and glycolysis, and the promotion effect on apoptosis in ovarian cancer cells. This evidence concerns the gene CDH1 and ovarian cancer.